vs
Ameriprise Financial（AMP）与CLOVER HEALTH INVESTMENTS, CORP.（CLOV）财务数据对比。点击上方公司名可切换其他公司
Ameriprise Financial的季度营收约是CLOVER HEALTH INVESTMENTS, CORP.的10.0倍（$4.9B vs $487.7M）。Ameriprise Financial净利率更高（18.7% vs -10.1%，领先28.8%）。CLOVER HEALTH INVESTMENTS, CORP.同比增速更快（44.7% vs 9.0%）。过去两年CLOVER HEALTH INVESTMENTS, CORP.的营收复合增速更高（18.6% vs 5.5%）
美国金融服务商Ameriprise Financial面向美国及全球其他地区的个人与机构客户提供多元化金融产品及服务，下设顾问与财富管理、资产管理、退休与保障解决方案、企业及其他四大业务板块，可满足客户财务规划、投资咨询、经纪服务等多方面需求。
克利弗健康投资公司是2014年成立的美国医疗保健企业，主营联邦医疗保险优势计划保险产品，是与美国政府直接签约合作的机构。目前公司为美国11个州的联邦医疗保险参保人提供健康管理服务，并已于2021年1月8日公开上市。
AMP vs CLOV — 直观对比
营收规模更大
AMP
是对方的10.0倍
$487.7M
营收增速更快
CLOV
高出35.7%
9.0%
净利率更高
AMP
高出28.8%
-10.1%
两年增速更快
CLOV
近两年复合增速
5.5%
损益表 — Q1 2026 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $4.9B | $487.7M |
| 净利润 | $915.0M | $-49.3M |
| 毛利率 | — | — |
| 营业利润率 | — | -10.1% |
| 净利率 | 18.7% | -10.1% |
| 营收同比 | 9.0% | 44.7% |
| 净利润同比 | 57.0% | -123.2% |
| 每股收益（稀释后） | — | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMPCLOV
| Q1 26 | $4.9B | — | ||
| Q4 25 | $5.0B | $487.7M | ||
| Q3 25 | $4.9B | $496.6M | ||
| Q2 25 | $4.5B | $477.6M | ||
| Q1 25 | $4.5B | $462.3M | ||
| Q4 24 | $4.6B | $337.0M | ||
| Q3 24 | $4.6B | $331.0M | ||
| Q2 24 | $4.4B | $356.3M |
净利润AMPCLOV
| Q1 26 | $915.0M | — | ||
| Q4 25 | $1.0B | $-49.3M | ||
| Q3 25 | $912.0M | $-24.4M | ||
| Q2 25 | $1.1B | $-10.6M | ||
| Q1 25 | $583.0M | $-1.3M | ||
| Q4 24 | $1.1B | $-22.1M | ||
| Q3 24 | $511.0M | $-9.2M | ||
| Q2 24 | $829.0M | $7.4M |
毛利率AMPCLOV
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 24.5% | ||
| Q2 24 | — | 30.3% |
营业利润率AMPCLOV
| Q1 26 | — | — | ||
| Q4 25 | 25.6% | -10.1% | ||
| Q3 25 | 24.0% | -4.9% | ||
| Q2 25 | 30.1% | -2.2% | ||
| Q1 25 | 15.3% | -0.3% | ||
| Q4 24 | 29.1% | -6.4% | ||
| Q3 24 | 14.1% | -2.7% | ||
| Q2 24 | 23.9% | 2.0% |
净利率AMPCLOV
| Q1 26 | 18.7% | — | ||
| Q4 25 | 20.0% | -10.1% | ||
| Q3 25 | 18.6% | -4.9% | ||
| Q2 25 | 23.6% | -2.2% | ||
| Q1 25 | 13.0% | -0.3% | ||
| Q4 24 | 23.0% | -6.6% | ||
| Q3 24 | 11.2% | -2.8% | ||
| Q2 24 | 18.9% | 2.1% |
每股收益（稀释后）AMPCLOV
| Q1 26 | — | — | ||
| Q4 25 | $10.39 | — | ||
| Q3 25 | $9.33 | — | ||
| Q2 25 | $10.73 | — | ||
| Q1 25 | $5.83 | — | ||
| Q4 24 | $10.57 | — | ||
| Q3 24 | $5.00 | — | ||
| Q2 24 | $8.02 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $8.3B | $78.3M |
| 总债务越低越好 | $3.3B | — |
| 股东权益账面价值 | $355.9B | $308.7M |
| 总资产 | $184.4B | $541.0M |
| 负债/权益比越低杠杆越低 | 0.01× | — |
8季度趋势，按日历期对齐
现金及短期投资AMPCLOV
| Q1 26 | $8.3B | — | ||
| Q4 25 | — | $78.3M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $194.5M | ||
| Q3 24 | — | $288.0M | ||
| Q2 24 | — | $254.8M |
总债务AMPCLOV
| Q1 26 | $3.3B | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益AMPCLOV
| Q1 26 | $355.9B | — | ||
| Q4 25 | $6.5B | $308.7M | ||
| Q3 25 | $6.5B | $340.9M | ||
| Q2 25 | $6.1B | $344.2M | ||
| Q1 25 | $5.4B | $336.1M | ||
| Q4 24 | $5.2B | $341.1M | ||
| Q3 24 | $5.7B | $342.2M | ||
| Q2 24 | $5.0B | $324.9M |
总资产AMPCLOV
| Q1 26 | $184.4B | — | ||
| Q4 25 | $190.9B | $541.0M | ||
| Q3 25 | $190.1B | $559.7M | ||
| Q2 25 | $184.9B | $575.0M | ||
| Q1 25 | $179.1B | $583.7M | ||
| Q4 24 | $181.4B | $580.7M | ||
| Q3 24 | $186.0B | $653.0M | ||
| Q2 24 | $179.7B | $674.2M |
负债/权益比AMPCLOV
| Q1 26 | 0.01× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-68.2M |
| 自由现金流经营现金流 - 资本支出 | — | $-68.7M |
| 自由现金流率自由现金流/营收 | — | -14.1% |
| 资本支出强度资本支出/营收 | — | 0.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-69.0M |
8季度趋势，按日历期对齐
经营现金流AMPCLOV
| Q1 26 | — | — | ||
| Q4 25 | $2.7B | $-68.2M | ||
| Q3 25 | $2.2B | $12.1M | ||
| Q2 25 | $1.8B | $5.4M | ||
| Q1 25 | $1.7B | $-16.3M | ||
| Q4 24 | $383.0M | $-85.8M | ||
| Q3 24 | $3.0B | $50.0M | ||
| Q2 24 | $1.7B | $44.8M |
自由现金流AMPCLOV
| Q1 26 | — | — | ||
| Q4 25 | $2.6B | $-68.7M | ||
| Q3 25 | $2.2B | $11.4M | ||
| Q2 25 | $1.7B | $4.8M | ||
| Q1 25 | $1.6B | $-16.5M | ||
| Q4 24 | $325.0M | $-86.1M | ||
| Q3 24 | $3.0B | $49.6M | ||
| Q2 24 | $1.7B | $44.4M |
自由现金流率AMPCLOV
| Q1 26 | — | — | ||
| Q4 25 | 52.0% | -14.1% | ||
| Q3 25 | 44.1% | 2.3% | ||
| Q2 25 | 38.4% | 1.0% | ||
| Q1 25 | 36.8% | -3.6% | ||
| Q4 24 | 7.0% | -25.6% | ||
| Q3 24 | 65.8% | 15.0% | ||
| Q2 24 | 38.8% | 12.5% |
资本支出强度AMPCLOV
| Q1 26 | — | — | ||
| Q4 25 | 0.9% | 0.1% | ||
| Q3 25 | 0.9% | 0.1% | ||
| Q2 25 | 0.8% | 0.1% | ||
| Q1 25 | 0.8% | 0.0% | ||
| Q4 24 | 1.2% | 0.1% | ||
| Q3 24 | 1.1% | 0.1% | ||
| Q2 24 | 0.4% | 0.1% |
现金转化率AMPCLOV
| Q1 26 | — | — | ||
| Q4 25 | 2.65× | — | ||
| Q3 25 | 2.42× | — | ||
| Q2 25 | 1.66× | — | ||
| Q1 25 | 2.89× | — | ||
| Q4 24 | 0.36× | — | ||
| Q3 24 | 5.96× | — | ||
| Q2 24 | 2.07× | 6.04× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMP
| Management and financial advice fees | $2.9B | 60% |
| Other | $872.0M | 18% |
| Distribution fees | $563.0M | 12% |
| Premiums, policy and contract charges | $341.0M | 7% |
| Other revenues | $166.0M | 3% |
CLOV
暂无分部数据
